Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes
Stefano Salciccia(Policlinico Umberto I), Martina Maggi(Policlinico Umberto I), Ettore De Berardinis(Policlinico Umberto I), Alessandro Sciarra(Policlinico Umberto I), Giovanni Battista Di Pierro(Policlinico Umberto I), Gian Maria Busetto(Sapienza University of Rome), Anna Laura Capriotti(Istituto Nazionale Biostrutture e Biosistemi), Peter R. Carroll(University of California, San Francisco), Mariantonia Logozzi(Organ Transplantation and Immunology Institute), Gian Piero Ricciuti(Policlinico Umberto I), Matthew R. Cooperberg(University of California, San Francisco), Beatrice Sciarra(Sapienza University of Rome), Stefano Fais(Organ Transplantation and Immunology Institute), Francesco Del Giudice(Sapienza University of Rome), Aldo Laganà(Istituto Nazionale Biostrutture e Biosistemi)
Cited by 109
Related Papers
High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
|PLoS ONE|2009|964
INTENSIVE LIFESTYLE CHANGES MAY AFFECT THE PROGRESSION OF PROSTATE CANCER
|The Journal of Urology|2005|474
Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility
|The World Journal of Men s Health|2019|468
Increased telomerase activity and comprehensive lifestyle changes: a pilot study
|The Lancet Oncology|2008|431